Clinical Utility of Pharmacogene Panel‐Based Testing in Patients Undergoing Percutaneous Coronary Intervention

We aimed to estimate the utility of panel‐based pharmacogenetic testing of patients undergoing percutaneous coronary intervention (PCI). Utilization of Clinical Pharmacogenetic Implementation Consortium (CPIC) level A/B drugs after PCI was estimated in a national sample of IBM MarketScan beneficiari...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Transl Sci
Asıl Yazarlar: El Rouby, Nihal, Alrwisan, Adel, Langaee, Taimour, Lipori, Gloria, Angiolillo, Dominick J, Franchi, Francesco, Riva, Alberto, Elsey, Amanda, Johnson, Julie A., Cavallari, Larisa H., Winterstein, Almut G.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2020
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7214641/
https://ncbi.nlm.nih.gov/pubmed/31758664
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cts.12729
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller